These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24484277)

  • 1. Advances of molecular imaging probes for the diagnosis of Alzheimer's disease.
    Zhou M; Wang X; Liu Z; Yu L; Hu S; Chen L; Zeng W
    Curr Alzheimer Res; 2014 Mar; 11(3):221-31. PubMed ID: 24484277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in molecular imaging for the diagnosis of dementia.
    Okamura N; Fodero-Tavoletti MT; Kudo Y; Rowe CC; Furumoto S; Arai H; Masters CL; Yanai K; Villemagne VL
    Expert Opin Med Diagn; 2009 Nov; 3(6):705-16. PubMed ID: 23496052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective.
    Hornberger J; Michalopoulos S; Dai M; Andrade P; Dilla T; Happich M
    J Ment Health Policy Econ; 2015 Jun; 18(2):63-73. PubMed ID: 26231002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of PET-imaging probes of β-amyloid plaques.
    Koo J; Byun Y
    Arch Pharm Res; 2013 Oct; 36(10):1178-84. PubMed ID: 23812777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of FDG and amyloid PET in Alzheimer's disease-A systematic review.
    Rice L; Bisdas S
    Eur J Radiol; 2017 Sep; 94():16-24. PubMed ID: 28941755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: novel PET/SPECT imaging probes for diagnosis of Alzheimer's disease.
    Ono M; Saji H
    J Pharmacol Sci; 2012; 118(3):338-44. PubMed ID: 22382657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
    Zeng F; Goodman MM
    Curr Top Med Chem; 2013; 13(8):909-19. PubMed ID: 23590167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of putative molecular imaging probes for BACE-1 by accounting for protein flexibility in virtual screening.
    Lang H; Huang X; Yang Y
    J Alzheimers Dis; 2012; 29(2):351-9. PubMed ID: 22232010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Past and recent progress of molecular imaging probes for β-amyloid plaques in the brain.
    Cui M
    Curr Med Chem; 2014; 21(1):82-112. PubMed ID: 23992340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel indanone derivatives as potential imaging probes for β-amyloid plaques in the brain.
    Qiao JP; Gan CS; Wang CW; Ge JF; Nan DD; Pan J; Zhou JN
    Chembiochem; 2012 Jul; 13(11):1652-62. PubMed ID: 22777884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
    Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
    Med Image Anal; 2018 May; 46():26-34. PubMed ID: 29502031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What does imaging add to the management of Alzheimer's disease?
    Small GW
    CNS Spectr; 2004 Jul; 9(7 Suppl 5):20-3. PubMed ID: 15241296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and acceptance of simultaneous amyloid PET/MRI.
    Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.